REGENERON PHARMACEUTICALS, INC. Insider Trading for May 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for May 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 19.69 | 5,000 | 98,450 | 10,000 | |
| May 29 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 515.00 | 5,000 | 2,575,000 | 112,772 | 117.8 K to 112.8 K (-4.25 %) |
| May 29 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 19.69 | 5,000 | 98,450 | 117,772 | 112.8 K to 117.8 K (+4.43 %) |
| May 27 2015 | REGN | REGENERON PHARMACE ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | M | 293.53 | 6,667 | 1,956,965 | 13,333 | |
| May 27 2015 | REGN | REGENERON PHARMACE ... | INGRAM ROBERT ALEXANDER | Director | Sell | S | 513.39 | 1,379 | 707,965 | 1,500 | 2.9 K to 1.5 K (-47.90 %) |
| May 27 2015 | REGN | REGENERON PHARMACE ... | INGRAM ROBERT ALEXANDER | Director | Payment of Exercise | F | 516.48 | 3,788 | 1,956,426 | 2,879 | 6.7 K to 2.9 K (-56.82 %) |
| May 27 2015 | REGN | REGENERON PHARMACE ... | INGRAM ROBERT ALEXANDER | Director | Buy | M | 293.53 | 6,667 | 1,956,965 | 6,667 | 0 to 6.7 K |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 26,250 | 804,038 | 57,986 | |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 13,800 | 293,250 | 4,095 | |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 510.02 | 99 | 50,492 | 0 | 99 to 0 (-100.00 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 509.34 | 7,506 | 3,823,106 | 99 | 7.6 K to 99 (-98.70 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 508.53 | 3,886 | 1,976,148 | 7,605 | 11.5 K to 7.6 K (-33.82 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 507.34 | 6,879 | 3,489,992 | 11,491 | 18.4 K to 11.5 K (-37.45 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 516.48 | 6,823 | 3,523,943 | 18,370 | 25.2 K to 18.4 K (-27.08 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 516.48 | 567 | 292,844 | 25,193 | 25.8 K to 25.2 K (-2.20 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 13,800 | 293,250 | 25,760 | 12 K to 25.8 K (+115.38 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 516.48 | 12,734 | 6,576,856 | 11,960 | 24.7 K to 12 K (-51.57 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 516.48 | 1,556 | 803,643 | 24,694 | 26.3 K to 24.7 K (-5.93 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 26,250 | 804,038 | 26,250 | 0 to 26.3 K |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 179.13 | 13,000 | 2,328,690 | 13,000 | |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 464 | 14,212 | 0 | |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 464 | 14,212 | 4,945 | 4.5 K to 4.9 K (+10.35 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 515.60 | 13,000 | 6,702,800 | 4,481 | 17.5 K to 4.5 K (-74.37 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 179.13 | 13,000 | 2,328,690 | 17,481 | 4.5 K to 17.5 K (+290.11 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 514.81 | 2,000 | 1,029,620 | 20,000 | 22 K to 20 K (-9.09 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 513.74 | 2,000 | 1,027,480 | 22,000 | 24 K to 22 K (-8.33 %) |
| May 20 2015 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | C | 0.00 | 20,000 | 0 | 0 | |
| May 20 2015 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | C | 0.00 | 20,000 | 0 | 24,000 | 4 K to 24 K (+500.00 %) |
| May 18 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 57.11 | 5,000 | 285,550 | 3,000 | |
| May 18 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 495.00 | 5,000 | 2,475,000 | 0 | 5 K to 0 (-100.00 %) |
| May 18 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 57.11 | 5,000 | 285,550 | 5,000 | 0 to 5 K |